ObsEva (OBSV) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock OBSV vs. PYRGF, MAAQ, RVPH, KZR, CASI, DARE, AKTX, TENX, CVKD, and ALLRShould you be buying ObsEva stock or one of its competitors? The main competitors of ObsEva include PyroGenesis Canada (PYRGF), Mana Capital Acquisition (MAAQ), Reviva Pharmaceuticals (RVPH), Kezar Life Sciences (KZR), CASI Pharmaceuticals (CASI), Dare Bioscience (DARE), Akari Therapeutics (AKTX), Tenax Therapeutics (TENX), Cadrenal Therapeutics (CVKD), and Allarity Therapeutics (ALLR). These companies are all part of the "pharmaceutical products" industry. ObsEva vs. Its Competitors PyroGenesis Canada Mana Capital Acquisition Reviva Pharmaceuticals Kezar Life Sciences CASI Pharmaceuticals Dare Bioscience Akari Therapeutics Tenax Therapeutics Cadrenal Therapeutics Allarity Therapeutics PyroGenesis Canada (NASDAQ:PYRGF) and ObsEva (NASDAQ:OBSV) are both small-cap pharmaceutical preparations industry companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability. Do institutionals & insiders hold more shares of PYRGF or OBSV? 0.0% of PyroGenesis Canada shares are owned by institutional investors. Comparatively, 17.5% of ObsEva shares are owned by institutional investors. 47.7% of PyroGenesis Canada shares are owned by company insiders. Comparatively, 14.4% of ObsEva shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, PYRGF or OBSV? PyroGenesis Canada has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, ObsEva has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500. Is PYRGF or OBSV more profitable? ObsEva has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat ObsEva's return on equity.Company Net Margins Return on Equity Return on Assets PyroGenesis Canada-115.14% N/A -60.81% ObsEva N/A -416.36%-92.01% Which has higher earnings and valuation, PYRGF or OBSV? PyroGenesis Canada has higher revenue and earnings than ObsEva. PyroGenesis Canada is trading at a lower price-to-earnings ratio than ObsEva, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPyroGenesis Canada$9.14M3.96-$21.12M-$0.03-6.43ObsEvaN/AN/A-$58.38M-$0.92N/A Does the media refer more to PYRGF or OBSV? In the previous week, PyroGenesis Canada's average media sentiment score of 0.00 equaled ObsEva'saverage media sentiment score. Company Overall Sentiment PyroGenesis Canada Neutral ObsEva Neutral SummaryPyroGenesis Canada beats ObsEva on 7 of the 10 factors compared between the two stocks. Get ObsEva News Delivered to You Automatically Sign up to receive the latest news and ratings for OBSV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OBSV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OBSV vs. The Competition Export to ExcelMetricObsEvaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.94M$736.37M$5.84B$10.14BDividend YieldN/A4.84%5.68%4.60%P/E Ratio0.001.1775.4125.98Price / SalesN/A26.64515.81181.13Price / CashN/A19.5637.5660.44Price / BookN/A6.6812.156.29Net Income-$58.38M-$4.13M$3.29B$271.07M ObsEva Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OBSVObsEvaN/AN/AN/AN/A$7.94MN/A0.0050PYRGFPyroGenesis CanadaN/A$0.17-9.9%N/A-67.9%$31.62M$9.14M-2.8190Gap UpMAAQMana Capital AcquisitionN/A$3.71+0.6%N/A+1,200.6%$30.14MN/A0.001RVPHReviva Pharmaceuticals2.9937 of 5 stars$0.44-2.0%$5.20+1,087.2%-63.1%$29.78MN/A-0.675KZRKezar Life Sciences3.9398 of 5 stars$4.02+0.1%$9.00+124.2%-30.7%$29.39M$7M-0.4160News CoveragePositive NewsAnalyst UpgradeCASICASI Pharmaceuticals3.7765 of 5 stars$2.34-0.4%$4.00+70.9%-68.2%$28.78M$28.54M-0.81180DAREDare Bioscience2.3215 of 5 stars$2.11-0.9%$10.00+373.9%-36.3%$28.44M-$17.70K-0.9930Short Interest ↓AKTXAkari Therapeutics3.7272 of 5 stars$0.85flat$3.30+288.2%-76.2%$27.73MN/A0.009Analyst ForecastShort Interest ↓TENXTenax Therapeutics2.2575 of 5 stars$6.04-0.1%$18.00+198.3%+60.4%$27.54MN/A-6.569High Trading VolumeCVKDCadrenal Therapeutics3.5181 of 5 stars$13.22-1.1%$32.00+142.1%+28.8%$27.10MN/A-1.494Short Interest ↓Gap DownALLRAllarity Therapeutics1.9565 of 5 stars$1.84-2.4%$9.00+390.5%-51.3%$26.83MN/A0.0010Short Interest ↑ Related Companies and Tools Related Companies PyroGenesis Canada Alternatives Mana Capital Acquisition Alternatives Reviva Pharmaceuticals Alternatives Kezar Life Sciences Alternatives CASI Pharmaceuticals Alternatives Dare Bioscience Alternatives Akari Therapeutics Alternatives Tenax Therapeutics Alternatives Cadrenal Therapeutics Alternatives Allarity Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OBSV) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina’s message to TrumpDid China just fire shots at America? Last week, in Tiananmen Square, China put on a chilling display of mi...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ObsEva SA Please log in to your account or sign up in order to add this asset to your watchlist. Share ObsEva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OBSV Stock Alerts